Onbrez Breezhaler
Onbrez Breezhaler, containing Indacaterol, is a long-acting bronchodilator designed for once-daily use to manage symptoms of chronic obstructive pulmonary disease (COPD). Indacaterol works by relaxing the muscles of the airways, providing long-lasting relief from breathing difficulties. The medication is administered via an inhalation capsule, ensuring direct delivery to the lungs for rapid action. It helps improve lung function, reduce breathlessness, and enhance the quality of life for those with COPD. Onbrez Breezhaler is specifically formulated for adults with chronic respiratory conditions, offering a convenient and effective solution for daily management. Its unique delivery system is designed to maximize efficacy and patient compliance.Active substance:
Indacaterol maleatePharmachologic effect:
Indacaterol is a long-acting beta2-adrenergic agonist that works by relaxing muscles in the airways to improve breathing.Indications:
- Maintenance treatment of chronic obstructive pulmonary disease (COPD)
Contraindications:
- Hypersensitivity to indacaterol or any of the excipients
- Asthma
Side effects:
In order of decreasing probability: Common: Cough, nasopharyngitis, headache, Uncommon: Dizziness, muscle spasms, rash, Rare: Hypersensitivity reactions, paradoxical bronchospasm
Dosing and Administration:
The recommended dose is one capsule inhaled once daily using the Breezhaler inhaler device.
Storage:
Store at a temperature not exceeding 30°C (86°F).
Onbrez Breezhaler
in Cyrillic : Онбрез Бризхалер
SUBSTANCE
Indacaterol
DOSAGE FORM
capsules
